Loading...
YUPELRI And Ampreloxetine Will Capitalize On Secular Trends
n/a
n/a
AnalystHighTarget's Fair Value
n/a
1Y
82.7%7D
17.9%1Y
82.7%7D
17.9%You can edit this narrative until Sep 4 9:26 PM. Then, changes will post as Updates.
You can edit this narrative until Sep 4 9:26 PM. Then, changes will post as Updates.